Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT01494987

Public ClinicalTrials.gov record NCT01494987. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 9:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled, parallel-group, multi-center study to determine the effect of ranolazine when added to glimepiride on glycemic control in adults with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current treatment with stable sulfonylurea or metformin therapy in addition to diet and exercise.

Study identification

NCT ID
NCT01494987
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
431 participants

Conditions and interventions

Interventions

Drug · Behavioral

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2012 (Type not available)
Primary completion
Aug 2013 (Actual)
Completion
Aug 2013 (Actual)
Last update posted
Nov 18, 2014

2012 – 2013

United States locations

U.S. sites
46
U.S. states
20
U.S. cities
42
Facility City State ZIP Site status
Clinical Research Advantage/Desert Clinical Research, LLC Mesa Arizona 85213 —
Desert Sun Clinical Research, LLC Tucson Arizona 85710 —
Eclipse Clinical Research Tucson Arizona 85745 —
Paul W. Davis, MD, PA Pine Bluff Arkansas 71603 —
Southland Clinical Research Center, Inc. Fountain Valley California 92708 —
Valley Research Fresno California 93720-2992 —
Del Rosario Medical Clinic, Inc. Huntington Park California 90255 —
Scripps Whittier Diabetes Institute La Jolla California 92037 —
National Research Institute Los Angeles California 90057 —
Spectrum Clinical Research Institute, Inc Moreno Valley California 92553 —
Sacramento Heart and Vascular Medical Associates Sacramento California 95825 —
Infosphere Clinical Research West Hills California 91307 —
PAB Clinical Research Brandon Florida 33511 —
Florida Research Network, LLC Gainesville Florida 32605-4253 —
NewPhase Clinical Trials, Inc. Miami Beach Florida 33140 —
Suncoast Clinical Research New Port Richey Florida 34652 —
Regenerate Clinical Trials South Miami Florida 33143 —
Comprehensive Clinical Development, Inc. St. Petersburg Florida 33716 —
Clinical Research of Central Florida Winter Haven Florida 33880 —
Synergy Therapeutic Partners Atlanta Georgia 30127 —
CTL Research Eagle Idaho 83616 —
Cedar-Crosse Research Center Chicago Illinois 60607 —
LaPorte County Institute for Clinical Research Michigan City Indiana 46360 —
L-MARC Research Center Louisville Kentucky 40213 —
Horizon Research Group of Opelousas Eunice Louisiana 70535 —
MD Medical Research Oxon Hill Maryland 20745 —
IRC Clinics, Inc Towson Maryland 21204 —
Endeavor Medical Research, PLC Alpena Michigan 49707 —
Associated Internal Medicine Specialists, P.C. Battle Creek Michigan 49015 —
Albuquerque Clinical Trials Albuquerque New Mexico 87102 —
PMG Research of Charlotte Charlotte North Carolina 28209 —
PharmQuest Greensboro North Carolina 27408 —
Clinical Inquest Center, Ltd. Beavercreek Ohio 45431 —
Infinity Research Group, LLC Oklahoma City Oklahoma 73103 —
Southeastern Research Associates, Inc. Taylors South Carolina 29687 —
HCCA Clinical Research Solution Franklin Tennessee 37067 —
Holston Medical Group Kingsport Tennessee 37660-3256 —
New Phase Research & Development Knoxville Tennessee 37923 —
The University of Texas Southwestern Medical Center at Dallas Dallas Texas 75390 —
Excel Clinical Research, LLC Houston Texas 77081 —
Texas Center for Drug Development, Inc. Houston Texas 77081 —
Humble Cardiology Associates Humble Texas 77338 —
Cetero Research San Antonio Texas 78229 —
Cetero Research San Antonio Texas 78237 —
Highland Clinical Research Salt Lake City Utah 84124 —
Jean Brown Research Salt Lake City Utah 84124 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01494987, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2014 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01494987 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →